Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

ADP National Employment Report: Private Sector Employment Increased by 54,000 Jobs in August; Annual Pay was Up 4.4%

(NASDAQ:ADP) ROSELAND, N.J., Sept. 4, 2025 /PRNewswire/ -- Private sector employment increased by 54,000 jobs in August and pay was up 4.4 percent year-over-year according to the August ADP Nationa...

Does the ADP employment data match the latest BLS figures, and could any divergence create a market‑moving catalyst? How does the 4.4% year‑over‑year pay increase compare to current inflation expectations and corporate earnings forecasts? Will the stronger private‑sector job growth affect the Federal Reserve’s rate‑path outlook and risk‑asset prices?
Symbol: ADP
Employment
1 day ago
Read more prnewswire

Palo Alto Networks Unveils Protection for Highly Evasive Threats with Prisma Access Browser, Extending SASE Leadership

(NASDAQ:PANW) Prisma SASE 4.0 protects against highly evasive threats that assemble inside the browser, offers AI-augmented data classification, and secures today's dynamic private applications Sca...

Will the announcement influence PANW’s stock valuation and trading volume given the $1.3 B ARR milestone and the positive sentiment score? How does this new SASE offering compare to competitors' products such as Zscaler's and Cisco's solutions in terms of market adoption and pricing power? What immediate effect will the Prisma Access Browser launch have on Palo Alto Networks' quarterly revenue and earnings forecasts?
Symbol: PANW
Product launch
1 day ago
Read more prnewswire

Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test

(NASDAQ:GH) PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a positive clinical readout update assessing the pe...

What is the expected timeline for FDA approval and commercial rollout of the V2 algorithm, and how might that influence short‑term stock volatility? What are the implications of the 84% sensitivity and 90% specificity compared to existing colorectal cancer screening methods and competitors in the market? How will the updated clinical results for Shield's V2 algorithm affect Guardant Health's revenue forecasts and valuation?
Symbol: GH
Clinical trials
1 day ago
Read more businesswire